nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—HTR2A—Alzheimer's disease	0.194	0.522	CbGaD
Methotrimeprazine—CYP2D6—Alzheimer's disease	0.177	0.478	CbGaD
Methotrimeprazine—HTR2A—Donepezil—Alzheimer's disease	0.143	0.362	CbGbCtD
Methotrimeprazine—DRD2—Memantine—Alzheimer's disease	0.114	0.289	CbGbCtD
Methotrimeprazine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0596	0.151	CbGbCtD
Methotrimeprazine—CYP2D6—Donepezil—Alzheimer's disease	0.0476	0.12	CbGbCtD
Methotrimeprazine—CYP2D6—Galantamine—Alzheimer's disease	0.0307	0.0776	CbGbCtD
Methotrimeprazine—HTR2C—choroid plexus—Alzheimer's disease	0.0114	0.124	CbGeAlD
Methotrimeprazine—DRD3—telencephalic ventricle—Alzheimer's disease	0.00602	0.0653	CbGeAlD
Methotrimeprazine—HTR2A—choroid plexus—Alzheimer's disease	0.00574	0.0622	CbGeAlD
Methotrimeprazine—DRD1—telencephalic ventricle—Alzheimer's disease	0.00431	0.0467	CbGeAlD
Methotrimeprazine—HTR2A—locus ceruleus—Alzheimer's disease	0.00354	0.0384	CbGeAlD
Methotrimeprazine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00335	0.0363	CbGeAlD
Methotrimeprazine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00289	0.0313	CbGeAlD
Methotrimeprazine—Sudden death—Memantine—Alzheimer's disease	0.00266	0.114	CcSEcCtD
Methotrimeprazine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00255	0.0276	CbGeAlD
Methotrimeprazine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00168	0.0182	CbGeAlD
Methotrimeprazine—DRD5—forebrain—Alzheimer's disease	0.00147	0.016	CbGeAlD
Methotrimeprazine—DRD5—telencephalon—Alzheimer's disease	0.00136	0.0147	CbGeAlD
Methotrimeprazine—Urinary retention—Galantamine—Alzheimer's disease	0.00134	0.057	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00128	0.0548	CcSEcCtD
Methotrimeprazine—ADRA1D—forebrain—Alzheimer's disease	0.00118	0.0128	CbGeAlD
Methotrimeprazine—DRD1—forebrain—Alzheimer's disease	0.00113	0.0122	CbGeAlD
Methotrimeprazine—ADRA1D—telencephalon—Alzheimer's disease	0.00109	0.0118	CbGeAlD
Methotrimeprazine—DRD1—telencephalon—Alzheimer's disease	0.00104	0.0112	CbGeAlD
Methotrimeprazine—Urinary retention—Donepezil—Alzheimer's disease	0.00103	0.0442	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000994	0.0424	CcSEcCtD
Methotrimeprazine—Urinary retention—Memantine—Alzheimer's disease	0.000939	0.0401	CcSEcCtD
Methotrimeprazine—DRD4—brain—Alzheimer's disease	0.000929	0.0101	CbGeAlD
Methotrimeprazine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000919	0.0393	CcSEcCtD
Methotrimeprazine—CHRM4—nervous system—Alzheimer's disease	0.000919	0.00995	CbGeAlD
Methotrimeprazine—CHRM2—forebrain—Alzheimer's disease	0.000908	0.00983	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000902	0.0385	CcSEcCtD
Methotrimeprazine—CHRM4—central nervous system—Alzheimer's disease	0.000884	0.00958	CbGeAlD
Methotrimeprazine—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000883	0.0377	CcSEcCtD
Methotrimeprazine—HTR2C—forebrain—Alzheimer's disease	0.000875	0.00948	CbGeAlD
Methotrimeprazine—Weight increased—Donepezil—Alzheimer's disease	0.000856	0.0366	CcSEcCtD
Methotrimeprazine—DRD3—nervous system—Alzheimer's disease	0.000854	0.00925	CbGeAlD
Methotrimeprazine—CHRM2—telencephalon—Alzheimer's disease	0.000835	0.00904	CbGeAlD
Methotrimeprazine—HTR2A—blood vessel—Alzheimer's disease	0.000832	0.00901	CbGeAlD
Methotrimeprazine—CHRM1—forebrain—Alzheimer's disease	0.000826	0.00895	CbGeAlD
Methotrimeprazine—DRD3—central nervous system—Alzheimer's disease	0.000822	0.00891	CbGeAlD
Methotrimeprazine—Jaundice—Donepezil—Alzheimer's disease	0.000817	0.0349	CcSEcCtD
Methotrimeprazine—HTR2C—telencephalon—Alzheimer's disease	0.000805	0.00872	CbGeAlD
Methotrimeprazine—DRD5—nervous system—Alzheimer's disease	0.0008	0.00867	CbGeAlD
Methotrimeprazine—Weight increased—Memantine—Alzheimer's disease	0.000777	0.0332	CcSEcCtD
Methotrimeprazine—DRD5—central nervous system—Alzheimer's disease	0.00077	0.00835	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000762	0.0326	CcSEcCtD
Methotrimeprazine—Weight increased—Rivastigmine—Alzheimer's disease	0.00076	0.0325	CcSEcCtD
Methotrimeprazine—CHRM1—telencephalon—Alzheimer's disease	0.00076	0.00823	CbGeAlD
Methotrimeprazine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000745	0.0318	CcSEcCtD
Methotrimeprazine—CHRM3—forebrain—Alzheimer's disease	0.000739	0.00801	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—Alzheimer's disease	0.000718	0.00778	CbGeAlD
Methotrimeprazine—Agranulocytosis—Memantine—Alzheimer's disease	0.000711	0.0303	CcSEcCtD
Methotrimeprazine—CHRM4—brain—Alzheimer's disease	0.000702	0.00761	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—Alzheimer's disease	0.000691	0.00749	CbGeAlD
Methotrimeprazine—CHRM3—telencephalon—Alzheimer's disease	0.00068	0.00737	CbGeAlD
Methotrimeprazine—ADRA1A—forebrain—Alzheimer's disease	0.000679	0.00735	CbGeAlD
Methotrimeprazine—Tachycardia—Galantamine—Alzheimer's disease	0.000674	0.0288	CcSEcCtD
Methotrimeprazine—DRD2—forebrain—Alzheimer's disease	0.000665	0.00721	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—Alzheimer's disease	0.000656	0.00711	CbGeAlD
Methotrimeprazine—DRD3—brain—Alzheimer's disease	0.000653	0.00707	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—Alzheimer's disease	0.000642	0.00695	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—Alzheimer's disease	0.000632	0.00684	CbGeAlD
Methotrimeprazine—ADRA1A—telencephalon—Alzheimer's disease	0.000624	0.00676	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—Alzheimer's disease	0.000618	0.00669	CbGeAlD
Methotrimeprazine—Somnolence—Galantamine—Alzheimer's disease	0.000613	0.0262	CcSEcCtD
Methotrimeprazine—DRD2—telencephalon—Alzheimer's disease	0.000612	0.00663	CbGeAlD
Methotrimeprazine—DRD5—brain—Alzheimer's disease	0.000612	0.00663	CbGeAlD
Methotrimeprazine—DRD1—nervous system—Alzheimer's disease	0.000611	0.00662	CbGeAlD
Methotrimeprazine—ADRA2C—telencephalon—Alzheimer's disease	0.000595	0.00644	CbGeAlD
Methotrimeprazine—Constipation—Galantamine—Alzheimer's disease	0.00059	0.0252	CcSEcCtD
Methotrimeprazine—DRD1—central nervous system—Alzheimer's disease	0.000589	0.00638	CbGeAlD
Methotrimeprazine—Dimetacrine—ACHE—Alzheimer's disease	0.000551	0.086	CrCbGaD
Methotrimeprazine—CHRM5—brain—Alzheimer's disease	0.000549	0.00594	CbGeAlD
Methotrimeprazine—HRH1—forebrain—Alzheimer's disease	0.000526	0.00569	CbGeAlD
Methotrimeprazine—ADRA2A—forebrain—Alzheimer's disease	0.000516	0.00559	CbGeAlD
Methotrimeprazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000508	0.0217	CcSEcCtD
Methotrimeprazine—ADRA1B—brain—Alzheimer's disease	0.000501	0.00543	CbGeAlD
Methotrimeprazine—HTR2A—embryo—Alzheimer's disease	0.000496	0.00538	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—Alzheimer's disease	0.000493	0.00534	CbGeAlD
Methotrimeprazine—ADRA1D—brain—Alzheimer's disease	0.00049	0.00531	CbGeAlD
Methotrimeprazine—HRH1—telencephalon—Alzheimer's disease	0.000483	0.00524	CbGeAlD
Methotrimeprazine—Somnolence—Donepezil—Alzheimer's disease	0.000475	0.0203	CcSEcCtD
Methotrimeprazine—HTR2C—nervous system—Alzheimer's disease	0.000475	0.00515	CbGeAlD
Methotrimeprazine—ADRA2A—telencephalon—Alzheimer's disease	0.000475	0.00514	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—Alzheimer's disease	0.000474	0.00514	CbGeAlD
Methotrimeprazine—Tachycardia—Memantine—Alzheimer's disease	0.000474	0.0202	CcSEcCtD
Methotrimeprazine—DRD1—brain—Alzheimer's disease	0.000467	0.00506	CbGeAlD
Methotrimeprazine—CYP2E1—telencephalon—Alzheimer's disease	0.000464	0.00503	CbGeAlD
Methotrimeprazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000464	0.0198	CcSEcCtD
Methotrimeprazine—Constipation—Donepezil—Alzheimer's disease	0.000457	0.0195	CcSEcCtD
Methotrimeprazine—HTR2C—central nervous system—Alzheimer's disease	0.000457	0.00495	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—Alzheimer's disease	0.000449	0.00486	CbGeAlD
Methotrimeprazine—HTR2A—forebrain—Alzheimer's disease	0.000439	0.00475	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—Alzheimer's disease	0.000432	0.00468	CbGeAlD
Methotrimeprazine—Somnolence—Memantine—Alzheimer's disease	0.000432	0.0184	CcSEcCtD
Methotrimeprazine—Somnolence—Rivastigmine—Alzheimer's disease	0.000422	0.018	CcSEcCtD
Methotrimeprazine—Constipation—Memantine—Alzheimer's disease	0.000415	0.0177	CcSEcCtD
Methotrimeprazine—Constipation—Rivastigmine—Alzheimer's disease	0.000406	0.0174	CcSEcCtD
Methotrimeprazine—HTR2A—telencephalon—Alzheimer's disease	0.000404	0.00437	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—Alzheimer's disease	0.000401	0.00435	CbGeAlD
Methotrimeprazine—CYP2D6—forebrain—Alzheimer's disease	0.0004	0.00433	CbGeAlD
Methotrimeprazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000394	0.0168	CcSEcCtD
Methotrimeprazine—CHRM3—central nervous system—Alzheimer's disease	0.000386	0.00419	CbGeAlD
Methotrimeprazine—CHRM2—brain—Alzheimer's disease	0.000377	0.00408	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—Alzheimer's disease	0.000369	0.00399	CbGeAlD
Methotrimeprazine—CYP2D6—telencephalon—Alzheimer's disease	0.000368	0.00398	CbGeAlD
Methotrimeprazine—HTR2C—brain—Alzheimer's disease	0.000363	0.00393	CbGeAlD
Methotrimeprazine—DRD2—nervous system—Alzheimer's disease	0.000361	0.00391	CbGeAlD
Methotrimeprazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000358	0.0153	CcSEcCtD
Methotrimeprazine—ADRA1A—central nervous system—Alzheimer's disease	0.000355	0.00384	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—Alzheimer's disease	0.000351	0.0038	CbGeAlD
Methotrimeprazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00035	0.0149	CcSEcCtD
Methotrimeprazine—DRD2—central nervous system—Alzheimer's disease	0.000348	0.00377	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—Alzheimer's disease	0.000347	0.00376	CbGeAlD
Methotrimeprazine—CHRM1—brain—Alzheimer's disease	0.000343	0.00371	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—Alzheimer's disease	0.00034	0.00368	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—Alzheimer's disease	0.000338	0.00366	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—Alzheimer's disease	0.00033	0.00358	CbGeAlD
Methotrimeprazine—CHRM3—brain—Alzheimer's disease	0.000307	0.00332	CbGeAlD
Methotrimeprazine—HRH1—nervous system—Alzheimer's disease	0.000285	0.00309	CbGeAlD
Methotrimeprazine—Mesoridazine—HTR6—Alzheimer's disease	0.000283	0.0441	CrCbGaD
Methotrimeprazine—ADRA1A—brain—Alzheimer's disease	0.000282	0.00305	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—Alzheimer's disease	0.00028	0.00304	CbGeAlD
Methotrimeprazine—DRD2—brain—Alzheimer's disease	0.000276	0.00299	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—Alzheimer's disease	0.000275	0.00298	CbGeAlD
Methotrimeprazine—Fluphenazine—CALM1—Alzheimer's disease	0.000274	0.0428	CrCbGaD
Methotrimeprazine—CYP2E1—nervous system—Alzheimer's disease	0.000274	0.00297	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—Alzheimer's disease	0.00027	0.00292	CbGeAlD
Methotrimeprazine—ADRA2C—brain—Alzheimer's disease	0.000268	0.00291	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—Alzheimer's disease	0.000264	0.00286	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—Alzheimer's disease	0.000264	0.00286	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—Alzheimer's disease	0.000258	0.00279	CbGeAlD
Methotrimeprazine—Fluphenazine—HTR6—Alzheimer's disease	0.000247	0.0386	CrCbGaD
Methotrimeprazine—HTR2A—nervous system—Alzheimer's disease	0.000238	0.00258	CbGeAlD
Methotrimeprazine—HTR2A—central nervous system—Alzheimer's disease	0.000229	0.00249	CbGeAlD
Methotrimeprazine—Clomipramine—HTR6—Alzheimer's disease	0.000226	0.0353	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR6—Alzheimer's disease	0.000225	0.0351	CrCbGaD
Methotrimeprazine—HTR2A—cerebellum—Alzheimer's disease	0.000224	0.00243	CbGeAlD
Methotrimeprazine—Promethazine—CALM1—Alzheimer's disease	0.000222	0.0347	CrCbGaD
Methotrimeprazine—Trifluoperazine—CALM1—Alzheimer's disease	0.000219	0.0342	CrCbGaD
Methotrimeprazine—HRH1—brain—Alzheimer's disease	0.000218	0.00236	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—Alzheimer's disease	0.000217	0.00235	CbGeAlD
Methotrimeprazine—Perphenazine—CALM1—Alzheimer's disease	0.000217	0.0338	CrCbGaD
Methotrimeprazine—ADRA2A—brain—Alzheimer's disease	0.000214	0.00232	CbGeAlD
Methotrimeprazine—Thioridazine—HTR6—Alzheimer's disease	0.000213	0.0332	CrCbGaD
Methotrimeprazine—CYP2E1—brain—Alzheimer's disease	0.00021	0.00227	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—Alzheimer's disease	0.000209	0.00226	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—Alzheimer's disease	0.000204	0.00221	CbGeAlD
Methotrimeprazine—Trifluoperazine—HTR6—Alzheimer's disease	0.000198	0.0308	CrCbGaD
Methotrimeprazine—Perphenazine—HTR6—Alzheimer's disease	0.000196	0.0305	CrCbGaD
Methotrimeprazine—Ethopropazine—BCHE—Alzheimer's disease	0.000193	0.03	CrCbGaD
Methotrimeprazine—HTR2A—brain—Alzheimer's disease	0.000182	0.00197	CbGeAlD
Methotrimeprazine—Chlorpromazine—CALM1—Alzheimer's disease	0.000172	0.0268	CrCbGaD
Methotrimeprazine—CYP2D6—brain—Alzheimer's disease	0.000166	0.0018	CbGeAlD
Methotrimeprazine—Triflupromazine—BCHE—Alzheimer's disease	0.000158	0.0246	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR6—Alzheimer's disease	0.000155	0.0242	CrCbGaD
Methotrimeprazine—Imipramine—HTR6—Alzheimer's disease	0.000154	0.0241	CrCbGaD
Methotrimeprazine—Mepyramine—CYP2D6—Alzheimer's disease	0.000151	0.0235	CrCbGaD
Methotrimeprazine—Cyamemazine—HTR2A—Alzheimer's disease	0.000136	0.0213	CrCbGaD
Methotrimeprazine—Mequitazine—CYP2D6—Alzheimer's disease	0.000108	0.0169	CrCbGaD
Methotrimeprazine—Diltiazem—CYP2D6—Alzheimer's disease	9.71e-05	0.0151	CrCbGaD
Methotrimeprazine—Acepromazine—HTR2A—Alzheimer's disease	8.76e-05	0.0137	CrCbGaD
Methotrimeprazine—Clomipramine—SLC6A4—Alzheimer's disease	8.66e-05	0.0135	CrCbGaD
Methotrimeprazine—Thioproperazine—HTR2A—Alzheimer's disease	8.56e-05	0.0134	CrCbGaD
Methotrimeprazine—Pipotiazine—HTR2A—Alzheimer's disease	8.42e-05	0.0131	CrCbGaD
Methotrimeprazine—Mesoridazine—HTR2A—Alzheimer's disease	8.31e-05	0.013	CrCbGaD
Methotrimeprazine—Trimipramine—SLC6A4—Alzheimer's disease	7.97e-05	0.0124	CrCbGaD
Methotrimeprazine—Pipotiazine—CYP2D6—Alzheimer's disease	7.7e-05	0.012	CrCbGaD
Methotrimeprazine—Chlorpromazine—BCHE—Alzheimer's disease	7.61e-05	0.0119	CrCbGaD
Methotrimeprazine—Mesoridazine—CYP2D6—Alzheimer's disease	7.6e-05	0.0119	CrCbGaD
Methotrimeprazine—Prochlorperazine—CYP2D6—Alzheimer's disease	7.36e-05	0.0115	CrCbGaD
Methotrimeprazine—Fluphenazine—HTR2A—Alzheimer's disease	7.28e-05	0.0114	CrCbGaD
Methotrimeprazine—Propiomazine—HTR2A—Alzheimer's disease	7e-05	0.0109	CrCbGaD
Methotrimeprazine—Clomipramine—HTR2A—Alzheimer's disease	6.66e-05	0.0104	CrCbGaD
Methotrimeprazine—Fluphenazine—CYP2D6—Alzheimer's disease	6.66e-05	0.0104	CrCbGaD
Methotrimeprazine—Chlorprothixene—HTR2A—Alzheimer's disease	6.63e-05	0.0103	CrCbGaD
Methotrimeprazine—Thioridazine—HTR2A—Alzheimer's disease	6.27e-05	0.00978	CrCbGaD
Methotrimeprazine—Trimipramine—HTR2A—Alzheimer's disease	6.13e-05	0.00955	CrCbGaD
Methotrimeprazine—Clomipramine—CYP2D6—Alzheimer's disease	6.09e-05	0.00949	CrCbGaD
Methotrimeprazine—Imipramine—SLC6A4—Alzheimer's disease	5.91e-05	0.00922	CrCbGaD
Methotrimeprazine—Promethazine—HTR2A—Alzheimer's disease	5.9e-05	0.0092	CrCbGaD
Methotrimeprazine—Trifluoperazine—HTR2A—Alzheimer's disease	5.82e-05	0.00907	CrCbGaD
Methotrimeprazine—Perphenazine—HTR2A—Alzheimer's disease	5.76e-05	0.00898	CrCbGaD
Methotrimeprazine—Thioridazine—CYP2D6—Alzheimer's disease	5.74e-05	0.00894	CrCbGaD
Methotrimeprazine—Trimipramine—CYP2D6—Alzheimer's disease	5.6e-05	0.00874	CrCbGaD
Methotrimeprazine—Promethazine—CYP2D6—Alzheimer's disease	5.39e-05	0.00841	CrCbGaD
Methotrimeprazine—Perphenazine—CYP2D6—Alzheimer's disease	5.26e-05	0.00821	CrCbGaD
Methotrimeprazine—Promazine—HTR2A—Alzheimer's disease	5.19e-05	0.00809	CrCbGaD
Methotrimeprazine—Chlorpromazine—HTR2A—Alzheimer's disease	4.57e-05	0.00712	CrCbGaD
Methotrimeprazine—Imipramine—HTR2A—Alzheimer's disease	4.54e-05	0.00708	CrCbGaD
Methotrimeprazine—Chlorpromazine—CYP2D6—Alzheimer's disease	4.18e-05	0.00651	CrCbGaD
Methotrimeprazine—Imipramine—CYP2D6—Alzheimer's disease	4.15e-05	0.00648	CrCbGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	4.17e-06	3.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	4.17e-06	3.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	4.16e-06	3.72e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	4.15e-06	3.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	4.15e-06	3.71e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	4.15e-06	3.71e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	4.14e-06	3.71e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CASP3—Alzheimer's disease	4.14e-06	3.7e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	4.13e-06	3.7e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	4.13e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	4.13e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—INS—Alzheimer's disease	4.13e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	4.12e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—GPCR downstream signaling—AKT1—Alzheimer's disease	4.12e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—INS—Alzheimer's disease	4.12e-06	3.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	4.12e-06	3.68e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—IL6—Alzheimer's disease	4.11e-06	3.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	4.11e-06	3.68e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	4.11e-06	3.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.1e-06	3.67e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	4.1e-06	3.66e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—LPL—Alzheimer's disease	4.09e-06	3.66e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	4.08e-06	3.65e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CASP3—Alzheimer's disease	4.08e-06	3.65e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	4.08e-06	3.65e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	4.07e-06	3.64e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	4.06e-06	3.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—IL6—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	4.06e-06	3.63e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	4.04e-06	3.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	4.04e-06	3.62e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	4.03e-06	3.6e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	4e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—Alzheimer's disease	4e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	3.99e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	3.99e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.99e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.99e-06	3.57e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	3.98e-06	3.56e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	3.98e-06	3.56e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	3.97e-06	3.55e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	3.96e-06	3.54e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	3.94e-06	3.53e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	3.93e-06	3.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.92e-06	3.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	3.91e-06	3.5e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	3.9e-06	3.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	3.85e-06	3.44e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	3.81e-06	3.41e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.81e-06	3.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	3.8e-06	3.4e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	3.79e-06	3.39e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.79e-06	3.39e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	3.78e-06	3.38e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	3.76e-06	3.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.75e-06	3.36e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	3.75e-06	3.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.74e-06	3.35e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	3.74e-06	3.35e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.72e-06	3.33e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	3.7e-06	3.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	3.69e-06	3.3e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	3.69e-06	3.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.68e-06	3.29e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.68e-06	3.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	3.66e-06	3.28e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IL6—Alzheimer's disease	3.66e-06	3.27e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	3.64e-06	3.25e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.62e-06	3.24e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	3.62e-06	3.24e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.61e-06	3.23e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	3.6e-06	3.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.6e-06	3.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	3.59e-06	3.21e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	3.58e-06	3.2e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.57e-06	3.2e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.56e-06	3.18e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	3.55e-06	3.17e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.54e-06	3.17e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	3.53e-06	3.16e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.52e-06	3.15e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	3.51e-06	3.14e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.48e-06	3.11e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	3.47e-06	3.1e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	3.47e-06	3.1e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.46e-06	3.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	3.44e-06	3.08e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.44e-06	3.08e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.43e-06	3.07e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	3.42e-06	3.06e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	3.42e-06	3.06e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.4e-06	3.04e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	3.39e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	3.39e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	3.38e-06	3.03e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	3.38e-06	3.02e-05	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	3.37e-06	3.02e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	3.37e-06	3.01e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	3.31e-06	2.96e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	3.3e-06	2.95e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.26e-06	2.91e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.25e-06	2.9e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	3.22e-06	2.88e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	3.18e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	3.18e-06	2.85e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.17e-06	2.83e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.16e-06	2.82e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.15e-06	2.82e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.13e-06	2.8e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	3.13e-06	2.8e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	3.12e-06	2.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	3.12e-06	2.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	3.11e-06	2.78e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	3.11e-06	2.78e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.1e-06	2.78e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.1e-06	2.77e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.09e-06	2.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.08e-06	2.75e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	3.08e-06	2.75e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	3.07e-06	2.74e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.06e-06	2.74e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	3.06e-06	2.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	3.05e-06	2.73e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	3.05e-06	2.73e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.05e-06	2.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.04e-06	2.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.04e-06	2.72e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	3.03e-06	2.71e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	3.02e-06	2.7e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	3.01e-06	2.69e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	3.01e-06	2.69e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	3e-06	2.68e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.99e-06	2.68e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.99e-06	2.67e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—Alzheimer's disease	2.95e-06	2.64e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.93e-06	2.62e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.92e-06	2.61e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.91e-06	2.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	2.91e-06	2.6e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.9e-06	2.6e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.88e-06	2.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.88e-06	2.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.87e-06	2.57e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.87e-06	2.57e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.86e-06	2.56e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.83e-06	2.53e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.82e-06	2.53e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.82e-06	2.52e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.82e-06	2.52e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.81e-06	2.52e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.81e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.8e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	2.8e-06	2.51e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	2.8e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	2.79e-06	2.5e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	2.79e-06	2.49e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	2.78e-06	2.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.78e-06	2.48e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.77e-06	2.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.77e-06	2.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.76e-06	2.47e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.76e-06	2.47e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IL6—Alzheimer's disease	2.7e-06	2.41e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.68e-06	2.4e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	2.66e-06	2.38e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—Alzheimer's disease	2.65e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.65e-06	2.37e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	2.64e-06	2.36e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	2.62e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—Alzheimer's disease	2.62e-06	2.34e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.61e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.6e-06	2.33e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.6e-06	2.32e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	2.59e-06	2.31e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.57e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.57e-06	2.3e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.56e-06	2.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.56e-06	2.29e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.56e-06	2.29e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	2.55e-06	2.28e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.53e-06	2.26e-05	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	2.49e-06	2.23e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.48e-06	2.22e-05	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	2.46e-06	2.2e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.43e-06	2.18e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IL6—Alzheimer's disease	2.43e-06	2.17e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	2.4e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IL6—Alzheimer's disease	2.4e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.4e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.39e-06	2.14e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.38e-06	2.13e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	2.38e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.37e-06	2.12e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	2.36e-06	2.11e-05	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	2.35e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.35e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.35e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.35e-06	2.1e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.27e-06	2.03e-05	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	2.24e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—AKT1—Alzheimer's disease	2.23e-06	2e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	2.21e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	2.21e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	2.21e-06	1.98e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.18e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.18e-06	1.95e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	2.17e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	2.16e-06	1.94e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	2.08e-06	1.86e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	2.02e-06	1.81e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	2e-06	1.79e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.99e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.99e-06	1.78e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.97e-06	1.77e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.97e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.97e-06	1.76e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.96e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.96e-06	1.75e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.94e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.93e-06	1.73e-05	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.92e-06	1.72e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	1.87e-06	1.67e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.84e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.83e-06	1.64e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.81e-06	1.62e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.81e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.8e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.8e-06	1.61e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.79e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.79e-06	1.6e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.77e-06	1.59e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.77e-06	1.58e-05	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	1.51e-05	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.67e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.66e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.66e-06	1.49e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.66e-06	1.48e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.65e-06	1.48e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.64e-06	1.47e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.64e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.63e-06	1.46e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.51e-06	1.36e-05	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.18e-06	1.06e-05	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1e-06	8.95e-06	CbGpPWpGaD
